Increase of In Vivo Antitumoral Activity by CD40L (CD154) Gene Transfer Into Pancreatic Tumor Cell-Dendritic Cell Hybrids
Carsten Ziske(University of Bonn), Ingo G.H. Schmidt‐Wolf(University Hospital Bonn), Alex-S. Eliu, Tilman Sauerbruch(University Hospital Bonn), Maria A. González-Carmona(University of Bonn), John Strehl(University of Bonn), Peter Brossart(University of Bonn), Dimitri Flieger(Klinikum Aschaffenburg), Marcus Gorschlüter(University of Bonn), Davorka Messmer(Nurix (United States)), Volker Schmitz(University of Bonn), Elisabeth Sievers(Karolinska University Hospital), Patricia E. Etzrodt
Cited by 13
Related Papers
<i>RUNX1</i>Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
|Journal of Clinical Oncology|2011|450
Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantation
|Blood|2014|400
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
|Journal of Clinical Oncology|2016|394
Experimental liver fibrosis research: update on animal models, legal issues and translational aspects
|Fibrogenesis & Tissue Repair|2013|330
ISO-1 Binding to the Tautomerase Active Site of MIF Inhibits Its Pro-inflammatory Activity and Increases Survival in Severe Sepsis
|Journal of Biological Chemistry|2005|316